Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 148Breast 13Head & Neck 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Gynecologic 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × bicalutamide × Other × Clear all
NCT00541047 2023-11-13

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

University College, London

Phase 3 Completed
4,236 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡